• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

CSAM: Transactions carried out under the share buy-back programme

OMDARegulatory press release16.06.2023 klo 13.10
Please see below information about transactions made under the share buy-back
programme for CSAM Health Group AS ("CSAM" or the "Company") (Ticker: CSAM NO).

Date on which the share buy-back programme was announced: 30 November 2022.

The duration of the buy-back programme: 20 January 2023 until and including the
day before the Company's Annual General Meeting in 2024.

Size of the buy-back programme: Up to 666,666 shares, for a maximum
consideration of NOK 20,000,000.

From 7 June 2023 until 15 June 2023 CSAM has purchased a total of 1,762 own
shares at an average price of 42.8264 per share.

Aggregated overview of transactions per day:

Date Aggregate daily volume (# of shares) Weighted average price (NOK) Total
transaction value (NOK)
07.06.2023 00:00:00 162 41.1000 6,658.20
08.06.2023 00:00:00 131 40.3588 5,287.00
09.06.2023 00:00:00 0 n.a. n.a.
12.06.2023 00:00:00 0 n.a. n.a.
13.06.2023 00:00:00 1,374 43.3224 59,524.98
14.06.2023 00:00:00 95 42.0000 3,990.00
15.06.2023 00:00:00 0 n.a. n.a.

Previously disclosed buy-backs under the programme
(aggregate) 86,726 39.3194 3,410,015.26
Total purchased under the programme 88,488 39.3892 3,485,475.44

This information is published in accordance with the requirements in article 5
of the EU Market Abuse Regulation and subject to the disclosure requirements
pursuant to Section 5-12 of the Norwegian Securities Trading Act.

Appendix: A detailed overview of all transactions made under the buy-back
programme that have been carried out during the above-mentioned time period is
attached to this report.

For more information, please contact:
Einar Bonnevie
Chief Financial Officer
+47 91 55 45 32
einar.bonnevie@csamhealth.com

About CSAM
CSAM Health Group is the leading provider of specialised software for healthcare
in the Nordics. From this solid foundation the company has grown to serve more
than 500 customers in 27 countries. Our highly specialised software solutions
are instrumental in the clinical care processes of healthcare providers and in
enabling emergency responders to enhance public safety. CSAM's headquarters are
in Oslo, Norway. CSAM has almost 300 dedicated specialists in ten countries
across Europe, Asia, Oceania and North America, including a wholly owned
software engineering subsidiary in the Philippines.

For more information, visit www.csamhealth.com
Follow us on LinkedIn
Subscribe to our newsletter: http://eepurl.com/dsoOJH